Medicure (CVE:MPH) Stock Price Passes Above 50 Day Moving Average of $1.06

Medicure Inc. (CVE:MPH) shares crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$1.06 and traded as high as C$1.17. Medicure shares last traded at C$1.02, with a volume of 4,400 shares changing hands.

Medicure Stock Down 6.4 %

The company has a quick ratio of 1.29, a current ratio of 1.92 and a debt-to-equity ratio of 2.73. The company has a market capitalization of C$10.65 million, a PE ratio of -11.33 and a beta of 1.01. The stock has a 50-day moving average of C$1.06 and a 200 day moving average of C$1.18.

Medicure (CVE:MPH) last issued its quarterly earnings results on Monday, April 8th. The company reported C($0.14) EPS for the quarter. The business had revenue of C$5.07 million for the quarter. Medicure had a negative net margin of 4.25% and a negative return on equity of 4.51%. Sell-side analysts anticipate that Medicure Inc. will post 0.0749258 EPS for the current year.

Medicure Company Profile

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.